| Particulars |
| Company Name |
Fredun Pharmaceuticals Ltd |
| Face Value |
10 |
| BSE Code |
539730 |
| Year End |
202603 |
| Full Year |
| Equity (Rs . Cr) |
16.54 |
| B.V. (Rs) |
163.10 |
| Sales (Rs . Cr) |
635.47 |
| NP (Rs . Cr) |
33.21 |
| NP Var% |
60.00 |
| Div% |
7.00 |
| CPS (Rs) |
24.90 |
| EPS (Rs) |
20.10 |
| Traded Value(Rs . Lakhs) |
119.53 |
| 52 Week High |
1,600.00 |
| 52 Week Low |
344.00 |
| Price BSE |
1,425.00 |
| Price NSE |
1,428.00 |
| Market Capital(Rs . Cr) |
2,356.34 |
| P/C Ratio |
57.30 |
| P/E Ratio |
71.00 |
| Price Vs.BV |
8.74 |
| Latest Quarter |
| Year End |
202606 |
| Sales (Rs . Cr) |
227.76 |
| NP (Rs . Cr) |
13.17 |
| NP Var % |
95.00 |
| Trailing Twelve Months |
| Year End |
202606 |
| Sales |
388.30 |
| OPM |
11.88 |
| NP |
17.69 |
| NP Var% |
89.58 |
| EPS |
26.87 |
| PE |
53.03 |
|